TORONTO, July 10, 2017 – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”), is pleased to announce that its wholly-owned subsidiary, Solace Health Inc. (“Solace Health”), has been granted a license to cultivate cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”). Strategically located in Mississauga, ON, and a short distance from Toronto’s Pearson International Airport, Solace Health will begin cultivating medical cannabis in Phase 1 of its 67,300 square foot facility, overseen by a qualified management team with strong health care and production experience.
“We are thrilled to have received a license to cultivate cannabis under Canada’s ACMPR,” commented Basem Hanna, President & Chief Executive Officer. “Our team understands that a license to cultivate is just the beginning of what’s to come for TerrAscend and Solace Health. TerrAscend, through its subsidiaries, aims to be a leading provider of cannabis products, services, and supporting technologies to the medical market. We’d like to thank all of our stakeholders that have contributed to this achievement over the past three years and we look forward to continuing to grow and promote the Solace Health brand.”